GlassScriptPhysician profile
Yanshu Cheng
NPI 1134681612
$633.82
in general payments reported to CMS, 2019-2025
18 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.32 · 2020: $57.63 · 2021: $60.48 · 2022: $16.13 · 2023: $159 · 2024: $154 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $102.95 | 2023 | |
| Exeltis, USA INC. | $70.77 | 2023-2025 | Slynd |
| Kci USA, INC. | $43.07 | 2019-2022 | |
| Sage Therapeutics, LLC | $42.35 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $37.60 | 2019-2021 | |
| Organon LLC | $37.19 | 2021-2023 | Jada System |
| Abbvie INC. | $36.91 | 2020 | |
| Minerva Surgical, INC | $34.40 | 2024 | |
| Hologic Sales and Service, LLC | $33.04 | 2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $31.83 | 2024-2025 | Veozah |
| Integra Lifesciences Corporation | $28.76 | 2024 | Medihoney, Biodrestore, Biofix |
| Medtronic, INC. | $27.00 | 2024 | V-Loc 180 |
| Supernus Pharmaceuticals, INC. | $20.74 | 2025 | Qelbree |
| Mission Pharmacal Company | $20.72 | 2020 | |
| Merck Sharp & Dohme LLC | $19.65 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $17.61 | 2019 | |
| Pfizer INC. | $16.93 | 2023 | |
| Boston Scientific Corporation | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanshu Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.